Skip to main content
Surendra Pal Chaudhary on Muck Rack

Surendra Pal Chaudhary

As seen in: European Journal of Cancer, Journal of Ayurveda Campus (JAC)
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Surendra Pal

Contact Surendra Pal, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Establishing the Precise Location of Apanga Marma and defining its Structural Component through Cadaveric Study

|
By Surendra Pal Chaudhary, Uma B. Gopal, Nepal Sanskrit
| Journal of Ayurveda Campus (JAC)
Authors Surendra Chaudhary Head; Department of Rachana Sharir, Central Ayurveda Campus, Institute of Ayurveda, Nepal Sanskrit University, Dang, Nepal Uma B.
Open in Who Shared Issue with article?

Modified gemcitabine and oxaliplatin or gemcitabine + cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trial

|
By Atul K. Sharma, BRA IRCH, Bidhu Kalyan Mohanti, Surendra Pal Chaudhary
| European Journal of Cancer Verified
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Fig. 2 Overall survival in mGemOx and CisGem group. OS, overall survival; mGemOx, modified gemcitabine and oxaliplatin; CisGem, gemcitabine + cisplatin. Highlights •No randomised controlled trials have compared CisGem and mGemOx in unresectable gallbladder cancer. •A phase III randomised equivalence study with 2 months of equivalence margin was conducted.
Open in Who Shared Issue with article?
See all 2 articles